Serco Group PLC

Director/PDMR Shareholding

RNS Number : 9402C
Serco Group PLC
20 June 2019
 

 

20 June 2019

Serco Group plc

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ACCORDANCE WITH ARTICLE 19 OF THE EU MARKET ABUSE REGULATION 596/2014

 

On 17 June 2019, Kevin Craven exercised 268,067 nominal-cost options, granted under the 2009 Serco Performance Share Plan.  128,517 Ordinary Shares of 2 pence each ('Ordinary Shares') were sold at 137 pence per Ordinary Share to satisfy tax liabilities and dealing costs. Immediately following the exercise, the remaining balance of 139,550 Ordinary Shares were transferred to his spouse for nil consideration.

 

Name of PDMR

Grant date of award

Vest date of award

Number of shares exercised

Number of shares sold

Share price

Number of shares retained

Kevin Craven

2 September 2014

2 September 2017

76,248

36,878

137 pence

39,370

29 May 2015

29 May 2018

191,819

91,639

137 pence

100,180

 

The notification of dealing forms can be found below.

 

Transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, UK and Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 



Identification code

ISIN: GB0007973794



b)

 

Nature of the transaction

 

 

The exercise of nominal-cost options over Ordinary Shares granted on 2 September 2014 and 29 May 2015 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£0.02

76,248




£0.02

191,819







d)

 

Aggregated information




- Aggregated volume

268,067



- Price

£5,361.34



e)

 

Date of the transaction

 

17 June 2019

f)

 

Place of the transaction

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 



Identification code

ISIN: GB0007973794



b)

 

Nature of the transaction

 

 

The sale of Ordinary Shares to satisfy tax liabilities and dealing costs following the exercise of nominal-cost options over Ordinary Shares on 6 June 2019 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£1.37

36,878




£1.37

91,639







d)

 

Aggregated information




- Aggregated volume

128,517



- Price

£176,068.29



e)

 

Date of the transaction

 

17 June 2019

f)

 

Place of the transaction

London Stock Exchange (XLON)



1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, UK and Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 



Identification code

ISIN: GB0007973794



b)

 

Nature of the transaction

 

 

The transfer of 139,550 Ordinary Shares to Spouse for nil consideration.

 

No change in beneficial ownership.

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£0.00

139,550







d)

 

Aggregated information



n/a (single transaction)

- Aggregated volume




- Price




e)

 

Date of the transaction

 

17 June 2019

f)

 

Place of the transaction

n/a



1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Amber Jane Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

PCA of Kevin Craven (CEO, UK and Europe)

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 



Identification code

ISIN: GB0007973794



b)

 

Nature of the transaction

 

 

Receipt of Ordinary Shares from spouse for nil consideration.

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£0.00

139,550







d)

 

Aggregated information



n/a (single transaction)

- Aggregated volume




- Price


e)

 

Date of the transaction

 

17 June 2019

f)

 

Place of the transaction

n/a

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHURRSRKKANUAR